Hypera SA (BSP:HYPE3)
R$ 20.95 -0.57 (-2.65%) Market Cap: 13.25 Bil Enterprise Value: 20.62 Bil PE Ratio: 7.90 PB Ratio: 1.11 GF Score: 88/100

Q4 2022 Hypera SA Earnings Call Transcript

Feb 17, 2023 / 02:00PM GMT
Release Date Price: R$44.06 (-4.90%)
Operator

Good morning Ladies and gentlemen, and welcome to the Hypera Pharma's conference call where we will discuss our earnings for 2022. We have with us Mr. Breno Oliveira, CEO; and Mr. Adalmario Couto, IRO. We'd like to inform you that this event is being recorded. You may access a recording of it in the company's Investor Relations website, hypera.com.br/ri. (Operator Instructions)

Before we continue, we'd like to underscore that some of the information in this conference call may refer to projections or statements on future expectations. This information is subject to known and unknown risks and uncertainties that may make them not come to pass or to be substantially different from what was expected. Now we'd like to give the floor to Mr. Breno Oliveira, who will begin the company's presentation. Mr. Breno, over to you.

Breno Toledo Pires de Oliveira
Hypera S.A. - CEO & Director

Good morning, everyone. Welcome to our earnings call for 2022 and for the fourth quarter of 2022. Last year was a very special one for Hypera. We reached all the guidance

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot